"Texas Digestive Disease Consultants in Southlake, Texas now offers Telemedicine and Telehealth services to provide greater convenience to our patients. With Telemedicine our patients will be able to receive gastroenterology treatment remotely from the comfort of their own home. We know that this will allow the residents of Southlake, Texas to receive a higher quality of gastrointestinal care from the qualified physicians of TDDC. Our Telemedicine provider is easy and free to use. Please contact our office to make an appointment today."

During the past decade, Texas Digestive Disease Consultants - Dallas conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 15 clinical trials were completed, i.e. on average, 53.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 14 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Digestive Disease Consultants - Dallas" #1 sponsor was "Celgene" with 7 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Digestive Disease Consultants - Dallas" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "ClinIntel" with 1 trials as a collaborator, "Clinical Reference Laboratory" with 1 trials as a collaborator, "DSG EDC" with 1 trials as a collaborator and "Diamond Pharma Services Regulatory Affairs Consultancy" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Texas Digestive Disease Consultants - Dallas" are "Ulcerative Colitis" (6 trials), "Nonalcoholic Steatohepatitis" (5 trials), "Colitis, Ulcerative" (4 trials), "Crohn Disease" (4 trials) and "Eosinophilic Esophagitis" (2 trials). Many other conditions were trialed in "Texas Digestive Disease Consultants - Dallas" in a lesser frequency.

Most popular intervention types in "Texas Digestive Disease Consultants - Dallas" are "Drug" (28 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Etrolizumab" (4 trials), "GED-0301" (4 trials), "Etrasimod" (3 trials) and "BMS-986036" (2 trials). Other intervention names were less common.

The vast majority of trials in "Texas Digestive Disease Consultants - Dallas" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Texas Digestive Disease Consultants - Dallas". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Texas Digestive Disease Consultants - Dallas, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Digestive Disease Consultants - Dallas, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Texas Digestive Disease Consultants - Dallas has several departments that took part in Clinical trials: "Texas Digestive Disease Consultants" - 6 trials, "Texas Digestive Disease Consultants - Webster" - 3 trials, "Texas Digestive Disease Consultants - Cedar Park" - 2 trials, "Texas Digestive Disease Consultants - Bay Area Houston Endoscopy Center" - 2 trials